Minister, another concern with these export controls from the EU is that even if they do not restrict vaccine exports to Canada, bureaucracy and paperwork for approval will slow down the process.
Are you aware of this concern? Did you raise this with your EU counterpart? Can you table for the committee any analysis that your department has done on how this might impact our vaccine strategies for procurement to Canada?